Editorial standards
Our editorial standards
CBD content touches on health and money. These rules apply to every page we publish, and they come before speed or traffic.
Evidence first
- Every product figure comes from a third-party ISO/IEC 17025 certificate of analysis, linked from the review.
- No figure is generated, estimated or completed by software, AI or guesswork. If data is missing, the page says “Not published”.
- Prices are shown with the date we checked them, because they change.
No health claims
We do not state or suggest that a CBD product treats, cures, prevents or relieves any disease or symptom, and we do not give dosage advice.
- United States: the FDA has not evaluated over-the-counter CBD products to diagnose, treat, cure or prevent any disease. The only FDA-approved CBD medicine is a prescription drug, and we never use it to promote consumer products.
- European Union: no health claim is authorised for CBD under Regulation (EC) No 1924/2006, and CBD as a food is assessed under the novel food rules.
Every review carries a compliance notice reminding readers that our content is not medical advice.
Independence
- Brands cannot buy a review, a rating or a position in a ranking.
- Affiliate links, when present, are labelled and never change the figures or the order.
Corrections
If you spot an error, a newer COA or a broken link, contact us. We check the report, correct the page and update the date shown on it.
Audience
CBDSpecs is written for adults. Laws on CBD and THC differ between countries and states; it is your responsibility to check the rules where you live.